Department of Medical and Molecular Genetics al., 1991; Pham-Dinh et al., 1991; Ikenaka et al., 1992 ; Indiana University School of Medicine Kamholz et al., 1992 ). The precise function(s) of PLP/ Indianapolis, Indiana 46202-5251 DM20 is unknown, but roles in adhesion between adjacent myelin lamellae (Boison et al., 1995) and as an ion channel have been proposed (Helynck et al., 1983) . Missense mutations of PLP cause a spectrum of CNS Summary disease. The most devastating of these, Pelizaeus-Merzbacher disease (PMD, MIM 312080) , is characterized by Alternative products of the proteolipid protein gene nystagmus, delayed psychomotor development, spas-(PLP), proteolipid protein (PLP) and DM20, are maticity, ataxia, and optic atrophy (Seitelberger, 1970) , and jor components of compact myelin in the central neris accompanied by widespread CNS dysmyelination vous system, but quantitatively minor constituents of (Seitelberger, 1984 (Seitelberger, , 1995 Koeppen et al., 1987 ; Iyoda Schwann cells. A family with a null allele of PLP has et al., 1988; Harding et al., 1995) . The age of onset and a less severe CNS phenotype than those with other rate of progression of PMD varies with the specific mutatypes of PLP mutations. Moreover, individuals with tion. Missense mutations of PLP can also cause a less PLP null mutations have a demyelinating peripheral severe syndrome, X-linked complicated spastic paraneuropathy, not seen with other PLP mutations of plegia (SPG) (Kobayashi et al., 1994 ; Saugier-Veber et humans or animals. Direct analysis of normal periphal., 1994; Osaka et al., 1995; Cambi et al., 1996) , which is eral nerve demonstrates that PLP is localized to comcharacterized by progressive lower extremity spasticity pact myelin. This and the clinical and pathologic observations of the PLP null phenotype indicate that and weakness, but without the widespread CNS dysmyelination and the clinical features typical of PMD. PLP/DM20 is necessary for proper myelin function both in the central and peripheral nervous systems.
Although PLP/DM20 is expressed by Schwann cells, missense mutations of PLP have not been associated Marks, 1990; Jasek et al., 1990; Wang et al., 1995) . Moreover, the thickness of the corpus callosum was of normal with peripheral nerve dysmyelination, by either electrodimensions for age, indicating that myelination had ocphysiologic or morphologic criteria (Hodes et al., 1993) . curred in this patient ( Figure 2C ). His evaluation for In fact, previous reports of PMD distinguish this disorder known causes of leukodystrophy, including adrenoleufrom other leukodystrophies, in part, by the absence of kodystrophy, was negative. PNS abnormalities (Wilkus and Farrell, 1976) . In addition, Autopsy material from three individuals in this family a detailed clinical, electrophysiological, and histological (V-5, death at age 47; V-6, death at age 45; and VI-6, examination of peripheral nerves in one patient with a death at age 34) was evaluated and findings were similar duplication of PLP causing PMD found no abnormalities for all three individuals. The gross pathology was notein the PNS (Harding et al., 1995) .
worthy for thinning of the corpus callosum, and gray In this report, we demonstrate that a novel PLP mutadiscoloration of the cerebral and cerebellar white matter. tion, a single base-pair deletion leading to the absence Microscopic pathology demonstrated normal neuronal of PLP/DM20 expression, produces a disease similar architecture of the cerebral and cerebellar cortex. The to, but less severe, than typical PMD, and which insubcortical white matter showed severe diffuse myelin cludes a progressive, demyelinating peripheral neuroploss, as assessed by histochemical staining, with better athy. Electrophysiological evidence of demyelinating preserved myelin in the subcortical U-fibers. peripheral neuropathy has been found in three affected
Since affected individuals had distal lower extremity individuals in this kindred; pathological verification of atrophy and distal proprioceptive loss, which suggested both central and peripheral demyelination has been a peripheral neuropathy, peripheral nerve function of found in autopsy material from two others. The presence four affected males was evaluated by nerve conduction of this demyelinating neuropathy clearly demonstrates velocity (NCV) measurements, summarized in Tables 1  that PLP/DM20 has an important function in the formaand 2. The distal motor latency (DML) is a measure of tion or maintenance of peripheral myelin in addition to conduction velocity in distal nerve segments, which do its well known function in central myelin. Consistent with not contribute to the determination of the nerve conducthis interpretation, we find by immunoelectron microstion velocity. F waves are of particular value in assessing copy that PLP is located in peripheral nerve compact conduction in nerve segments proximal to those where myelin, suggesting that PLP may play a structural role conduction velocities are measured (Kimura, 1974 ; in peripheral myelin as well. Young and Shahani, 1978; Panayiotopoulos and Chroni, 1996) . Affected patients often had DML or F-wave proResults longation that was out of proportion to the degree of nerve conduction slowing across the major segment of Identification of a Novel PLP Mutation Associated nerve. For example, at age 15, patient VI-7 had a median with Both PMD and Demyelinating DML of 6.3 ms, whereas his conduction velocity was 42 Peripheral Neuropathy m/s, suggesting a greater degree of conduction slowing A family with an X-linked leukodystrophy was identified across the wrist, which is characteristic of carpal tunnel (see pedigree, Figure 1 ). Affected males demonstrated syndrome. This patient had a very abnormal ulnar delay in both motor and cognitive development and had F-wave latency of 47 ms, which is prolonged beyond optic pallor, limb spasticity, mild atrophy of the legs, expectation given his NCV values, and demonstrated and decreased proprioception. Magnetic resonance imthe presence of proximal nerve demyelination. These aging (MRI) of the brain of patient VI-7 at age 15, shown data are consistent with a demyelinating neuropathy in Figure 2 , shows increased T 2 signal throughout the with multifocal conduction slowing. Mutations in the cerebral white matter, consistent with a leukodystrophy.
Cx32 coding region, and alteration in PMP22 copy numThe severity of signal abnormalities was judged milder ber were excluded (not shown). than those typically found in either connatal or classic
The neuropathic phenotype demonstrated linkage to DXS458 in Xq22 (lod ϭ 4.72 at ϭ 0). A mutation in PLP PMD (Journel et al., 1987; Andre et al., 1990; Caro and in three affected males in this family (VI-6, V-5, and producing a stop codon two amino acids downstream from the PLP initiation codon. Unambiguous assignment V-6) was identified by single-stranded conformational polymorphism analysis and further characterized by of which of the three G residues is deleted cannot be made, and for simplicity, we will designate the deleted DNA sequencing. A deletion of one G residue in a triplet of G residues, G-3, G-4, or G-5, numbered with respect G residue as G-4. to the PLP open reading frame, was identified in both individuals (see Figure 3) . This deletion preserves a conThe G-4 PLP Deletion Does Not Alter Splicing sensus splice donor sequence (Keller and Noon, 1984) Since the single base-pair deletion occurred in PLP im-3Ј of the deleted G residue, and is predicted to result, mediately 5Ј of the splice donor site of intron 1, we after splicing, in a frameshift of the PLP reading frame, analyzed the PLP mRNA structure directly to determine whether normal splicing occurred at this point. This is important, since normal splicing will produce a PLP mRNA encoding only the three amino acids, divergent from PLP after the initiation methionine, with the result that no functional PLP or DM20 can be synthesized. RNA was thus isolated from frozen brain tissue obtained at autopsy from one of the affected males (V-5), and subjected to reverse transcription-polymerase chain reaction (RT-PCR) analysis, using a primer pair spanning the intron 1 splice sites, and to Northern analysis. Two bands of expected sizes, 630 and 590 nucleotides, respectively, corresponding to the predicted alternatively spliced products, PLP and DM20, were obtained from both patient and control brain tissue in the RT-PCR study (data not shown). DNA sequence analysis of the RT-PCR product confirmed the presence of the G-4 deletion and the downstream stop codon (Figure 3 ). Northern analysis (Figure 4 ) demonstrated that the PLP mRNA from the affected individual was as long as that from a normal patient. Had the G-4 deletion prevented splicing, the mRNA length would be expected to be significantly increased since the normal length of intron 1 is ‫7ف‬ kb. These data thus demonstrate that the G-4 deletion does not alter the PLP splicing pattern, and should result in the inability to synthesize PLP/DM20.
The PLP G-4 Deletion Produces a Null PLP Allele with Absence of PLP and DM20 Expression To evaluate the effect of the G-4 deletion on PLP expression, we analyzed brain samples from patients V-5 and V-6 for PLP expression by Western blotting and immunohistochemistry. Northern analysis, shown in Figure 4 , demonstrates that PLP mRNA levels from the patient samples are essentially the same as those from control brain. In addition, the levels of myelin basic protein (MBP) and cyclic nucleotide phosphohydrolase (CNP) mRNAs, encoding two other myelin proteins, are also the same in patient and control brain. Therefore, the G-4 deletion has little effect on the accumulation of the steady state levels of other myelin-specific mRNAs. Western analysis of cerebral cortical tissue from individuals V-5 and V-6 demonstrated the complete absence of both PLP and the alternative PLP gene product, DM20, both in unfractionated protein extracts and in a purified myelin fraction ( Figure 5A ). MBP, however, is readily detectable both in patient and control samples ( Figure 5B ). In addition, the pattern of protein expression in both whole brain extracts and in crude myelin is qualitatively very similar between affected individuals and absence of both PLP and DM20 expression, but with Motor conduction velocity measurements of individuals in Pelizaeus-Merzbacher families. Where two velocity measurements for a nerve are reported, the first value is that above the joint (elbow for ulnar and median nerves; knee for the peroneal nerve) and the second value is that below the joint. The first II patients' values are from the family with the PLP G-4 deletion. RIII-5 and RII-1 (RIII-5's mother) are individuals with deletion of PLP as described by Raskind et al. (1991) . Pro15Leu is an affected male from the family described by Trofatter et al. (1989) . PMD, an individual with clinical classical Pelizaeus-Merzbacher disease, DML, distal motor latency; F, F wave latency; Nl, normal value, and NS, F-wave was not seen. *Value rechecked by examining physician but could not be verified by the authors. little effect on the expression of other major myelin prowere incubated with PLP-antibody to demonstrate its usefulness for detection of PLP in paraffin-embedded teins, such as MBP.
To evaluate the spatial pattern of myelin protein extissue. These observations are consistent with the Western blotting results, and demonstrate that PLP, but not pression directly, we examined brain tissue from patient V-5 by immunohistochemistry. As seen in Figures 6A and MBP, expression is absent in CNS white matter. Therefore, the area of demyelination most likely results from 6D, there is extensive demyelination in the subcortical white matter tracts as demonstrated by histochemical the absence of PLP. staining for myelin. In the same area, however, there is robust MBP staining ( Figures 6B and 6E ), but no immuIndividuals with the G-4 Deletion Have Morphological Evidence of an Asymmetric, Demyelinating noreactive PLP ( Figure 6C ). At higher magnification, MBP staining is associated with axons in the cerebellar Peripheral Neuropathy Morphological evaluation of the peripheral nerves of the white matter ( Figure 6E ). Specimens of normal human cerebellum ( Figure 6F ) and rat spinal cord (not shown) affected individuals in this kindred was performed on localized to compact myelin. To test this hypothesis, we analyzed rat peripheral nerve by immunoelectron microscopy with an antibody directed against the PLPspecific portion of the protein. The results of this experiment, shown in Figure 8 , demonstrate that PLP is present in adult rat nerve compact myelin.
Discussion
In this report, we describe a family with a novel PLP mutation, a deletion of G-4 of the PLP coding region, and demonstrate that this deletion produces a null PLP allele, such that neither PLP, nor its alternatively spliced product, DM20, is expressed. The absence of PLP/ DM20 expression produces a constellation of neurological signs and symptoms similar to, but less severe than CNS myelin, the G-4 deletion causes a progressive demyelinating peripheral neuropathy, demonstrated by both electrophysiological examination and neuropathoautopsy material available from individuals V-5 and V-6. logical analysis of autopsy specimens. These studies Consistent with the presence of a demyelinating neudemonstrate that PLP/DM20 is necessary in both peropathy, cross sections of the axillary ( Figure 7A ) and ripheral and central myelin in humans. We have also sciatic ( Figure 7B ) nerve revealed marked loss of large shown by immunoelectron microscopy that PLP is localand small myelinated fibers and endoneurial fibrosis, ized to peripheral compact myelin. Taken together, with occasional regenerating clusters. Preserved mythese observations suggest that PLP plays an important elinated fibers often demonstrated splitting and degrastructural role in PNS myelin. dation of the myelin sheath, which sometimes was accompanied by axonal atrophy and degeneration.
Comparison to Other Probable PLP Null Families Macrophages were seen but were not present in large Three additional families with null PLP mutations have numbers. The endoneurial vessels showed thickened been described previously. In two of these families, the basement membranes.
entire PLP gene along with surrounding sequences was To demonstrate demyelination more clearly, samples deleted (Raskind et al., 1991; Sugiyama et al., 1996) . A from both axillary and sciatic nerve were assessed by third family carries a G-to-A transition at the initiation teased fiber analysis. Scoring of teased fibers showed codon of the PLP gene, leading to predicted absence high frequencies of fibers with segmental demyelination of PLP/DM20 (Sistermans et al., 1996) . The clinical phe-( Figure 7C ) and paranodal demyelination (Figures 7D notype in affected males in these three families, similar and 7E) in both the axillary and sciatic nerves (Table  to the family reported here, is distinctly less severe than 3). Demyelination, particularly of the paranodal myelin, that described in connatal and classical cases of PMD. could also be identified in longitudinal sections (Figure The PNS was not formally evaluated in the two deletion 7E). Paranodal and segmental demyelination were families. Affected members of the family carrying a G-A prominent in longitudinal sections. Axonal atrophy, inditransition in the initiation codon of PLP were found to cated by excessive myelin wrinkling (Table 3) , and Walhave reduced conduction velocity on electrophysiologilerian degeneration were also observed. Taken together, cal examination and had reduced numbers of myelinthese data are consistent with the physiology and morated fibers in the sural nerve. No molecular or biochemiphology of a demyelinating peripheral neuropathy.
cal data confirming the absence of PLP/DM20 was reported. We have recently evaluated the peripheral PLP Is Located in Compact Myelin in the nerve function of an individual reported by Raskind and Peripheral Nerve coworkers (1991), and have found asymmetrical slowing Our data from this family demonstrate that a null allele of his NCVs, similar to that found for family members of PLP can produce both CNS and PNS demyelination.
carrying the PLP G-4 deletion (Lewis, unpublished data). Since PLP is the major CNS myelin protein, the presence These data further confirm the notion that PLP/DM20 is of CNS demyelination in these individuals is not unexnecessary in both PNS and CNS myelin, and that the pected. In contrast, PLP/DM20 is expressed at much absence of PLP/DM20 expression leads to myelin loss lower levels in the PNS, and the role, if any, of PLP/ in both brain and peripheral nerve. DM20 in the peripheral nervous system has not been determined. The presence of a demyelinating peripheral neuropathy in this family demonstrates that PLP/DM20
Comparison to PLP Knockout Mice Klugmann and coworkers (1997) recently reported the also has an important function in PNS myelin. One possible role for PLP/DM20 in PNS myelin is as a strucanalysis of a mouse line in which PLP had been inactivated by homologous recombination. Animals that do tural myelin protein, where it would be expected to be not express PLP/DM20 appear to have normal CNS and after birth. If this is the case, humans lacking PLP would form normal myelin during the first year of life, when PNS myelin function since they do not have any significant clinical disturbance of motor function. CNS comhuman myelination peaks. Myelin would then break down, leading to progressive neurological deterioration. pact myelin in the PLP knockout mouse has only subtle ultrastructural abnormalities. These findings clearly dif-
The clinical course of affected individuals carrying the G-4 deletion is consistent with this hypothesis. Motor fer from those in patients with either a null PLP allele or a PLP deletion, all of whom demonstrate clinical signs, and verbal skills are acquired during the first decade of life but then are gradually lost. In addition, the thickness symptoms, and MRI evidence of CNS myelin loss. Affected individuals carrying the G-4 deletion, for example, and signal intensity of the corpus callosum of individual VI-7 on MRI scan is normal at age 15, suggesting that have clear evidence of abnormal myelin on MRI scan (Figure 2) , and analysis of autopsy material from individmyelin was formed at this site. Other regions of the same scan, however, clearly demonstrate abnormalities of uals V-5 and V-6 demonstrates multiple areas devoid of myelin staining, both in brain and peripheral nerve myelin (Figure 2) . Finally, neuropathological evaluation of brain specimens from individuals V-5 and V-6 shows ( Figures 6 and 7) . The individual reported by Raskind et al. (1991) with a PLP deletion also has abnormal myelin areas of both relatively normal and abnormal myelination (data not shown). Taken together, these data are consisdemonstrated by MRI scan.
The reasons for the differences between humans and tent with the notion that CNS myelin is formed during development in individuals carrying the G-4 deletion, rodents that do not express PLP are not known. In their recent paper describing the PLP knockout mouse, Klugand subsequently breaks down, suggesting that PLP is necessary for myelin stability, but not for myelin formamann and coworkers (1997) postulate that PLP is more important for myelin stability in humans than in rodents, tion. While we cannot definitively explain the relative lack of neurobehavioral abnormalities in the knockout suggesting that human myelin without PLP is inherently unstable and eventually breaks down within a few years mice, possible reasons for the benign phenotype of the murine compared to the human null PLP condition inmatter of the PLP null patients are similar to those of normal brains, in contrast to what has been observed clude compensatory mechanisms, perhaps by altered expression of one or more myelin proteins; differences in the brains of other Pelizaeus-Merzbacher patients (Koeppen et al., 1987) or in the brains of the severe in absolute diameter of axons in mice relative to humans; and the effects of absolute or relative age. We speculate dysmyelinating murine PLP mutations, such as those of jimpy mice (Skoff, 1995) or md rats (Nadon and Duncan, that the knockout mice of Nave and coworkers will have evidence of demyelination in both the CNS and PNS if 1995) . In these examples, mature oligodendrocyte numbers and levels of myelin gene and protein expression they are examined at a significantly later age.
are severely reduced. These observations and the finding that PLP/DM20 is expressed during embryogenesis
Oligodendrocytes Develop Normally in the Absence of PLP/DM20
in what appear to be the earliest oligodendrocytes or their immediate precursors (Timsit et al., 1992 (Timsit et al., , 1995 ; Yu The ability of PLP null patients to form myelin indicates that oligodendrocytes developed normally in these indiet al., 1994) have suggested that PLP/DM20 could be important for the differentiation of oligodendrocytes viduals. Moreover, levels of myelin gene expression, as demonstrated by those of myelin basic protein and MBP (Timsit et al., 1992) . Our observations indicate that oligodendrocytes can develop and survive in the complete mRNA, and of PLP mRNA are comparable to those of normal brain (Figures 4 and 5) . Morphologically, the absence of PLP products. The severe alleles of PLP likely act at the cellular numbers of mature oligodendrocytes in the CNS white level in a dominant fashion to perturb maturation of 1994; Osaka et al., 1995) . That complete lack of PLP/ DM20 expression results in a less severe PMD syndrome oligodendrocytes, perhaps by a toxic effect of the abnormally folded and unprocessed protein (Gow et al., demonstrates that normal DM20 processing is not the only mechanism that can mitigate the effects of muta-1994; Nadon et al., 1994; Schneider et al., 1995 ). DM20 appears to be able to facilitate the processing of PLP tions affecting PLP. (Sinoway et al., 1994) . Mutations of PLP that spare DM20 or its processing generally have less severe phenotypes, PLP/DM20 Is Required for Normal Peripheral Nerve Function probably due to DM20 substituting for PLP in myelin or DM20 promoting the processing of the mutant PLP (Gow Most prior reports have not found evidence for peripheral neuropathy in patients with PMD. Hodes et al. (1993) and Lazzarini, 1996) . In particular, mutations that affect only PLP, but not DM20, are typically associated with reviewed their and others' clinical and genetic observations on patients with PMD and, except for the family the less severe SPG phenotype (Saugier-Veber et al., Frequencies of specific pathologic changes in teased fibers from the axillary and sciatic nerves. reported in detail here, failed to find evidence of periphthat PLP is a quantitatively minor component of peripheral nerve (Lemke, 1992) and the report by Puckett et eral neuropathy in other patients where mutations have been characterized. Furthermore, no morphological or al. (1987) that PLP in Schwann cells appears to be a cytoplasmic, rather than membrane associated protein, physiological abnormalities of peripheral nerve have been observed in jimpy mice or md rats, each of which raised the possibility that PLP did not serve an important role in peripheral nerve, or at least one not directly rehas a PLP mutation that produces severe CNS hypomyelination and demyelination. In addition, we have found lated to myelin structure. Agrawal and Agrawal (1991) on the other hand, using biochemical fractionation and no evidence of peripheral nerve dysfunction in a 20-year-old man with a severe form of PMD caused by a immunoprecipitation, provided evidence that PLP is a myelin protein in peripheral nerve. We provide the first missense mutation in codon 15 of the PLP coding region (Trofatter et al., 1989, and unpublished data perature was maintained at 31-32ЊC. Patients RIII-5 and RII-1 (patients III-5 and II-1, respectively, described by Raskind et al., 1991) branes. Trapp et al. (1997) have shown that in the CNS, were studied by G. H. K. Temperatures ranged from 30-36ЊC except premyelinating oligodendrocytes have PLP/DM20 stainfor the tibial nerve in patient RIII-5 recorded at 25ЊC. Surface elecing throughout the cell, whereas myelinating oligodentrodes were utilized in all studies, and sensory studies were antidrocytes express PLP only in the perinuclear cytoplasm dromic. Sensory velocities when determined were computed by and myelin internodes. Furthermore, since other investidividing the distal onset latency into the distance between stimulatgators have used antisera that recognize both PLP and ing cathode and proximal recording electrode. Normals were based on laboratory determined norms and published values (Gamstorp, DM20, it is possible that the relatively more abundant 1963; Baer and Johnson, 1965; Sunderland, 1968) . DM20 (Pham-Dinh et al., 1991 ) is primarily being deMembers of an Indiana kindred affected by a Pro15Leu mutation tected, and its signal overshadows that of PLP. The of PLP, and which has been described in several prior reports (Zeantiserum used for immunolocalization in our study has man et al., 1964; Markand et al., 1982; Trofatter et al., 1989) , were been tested in a variety of settings, including Western examined clinically and electrophysiologically. The clinical syndrome in this family is extremely severe and would correspond to blotting and light microscopic immunocytochemistry the connatal form of PMD, which includes seizures and growth and found to be both sensitive and specific (Asotra and retardation. In addition, several patients ranging from 4-28 years of Macklin, 1993; Duchala et al., 1995; Trapp et al., 1997) .
age with clinically definite PMD (Boulloche and Aicardi, 1986), but
The intriguing phylogenetic analyses of P0, DM20, and without defined mutations, were studied. Although point and other PLP by Yoshida and Colman (1996) Schwann cell to compensate for the absence of P0 amplified and sequenced as described by . The amplification primers for exon 1 were 5Ј-CTGGAGAGACCAGGATCC (Giese et al., 1992) .
TTCC-3Ј and 5Ј-TTCATGCTAAAGTTTTTGAAACTT-3Ј. Single nucleMissense PLP mutations are thought to act through otide primer extension was done as previously described by Pratt a dominant mechanism at the cellular level, suggesting et al. (1993) . The single nucleotide primer extension primer was that disturbed protein-protein interactions involving mu-5Ј-GTCAGAGTCCCAAAGACATGG-3Ј. ␣-32 P dGTP was used to detant PLP cause CNS demyelination (Gow et al., 1994;  tect the normal allele; ␣-32 P dTTP was used for the mutant allele; Schneider et al., 1995; Gow and Lazzarini, 1996) . Since and ␣-32 P dATP was used as a negative control.
peripheral nerve function is normal in patients with mis- sibility that other mutations affecting PLP may result
Mbp region associated with CMT1A by normalized Southern blot in phenotypes that predominantly or even exclusively hybridization according to Chen et al. (1996) , and complete sequencing of the coding exon of Cx32 (GJB1) was performed acaffect the PNS.
cording to Bergoffen et al. (1993) .
Nerve conduction studies of individuals carrying the G-4 deletion show multifocal, asymmetric slowing of RNA Analysis both motor and sensory conductions. This pattern of Slices of frontal lobes from individuals V-5 and V-6 were frozen nerve conduction abnormality is distinct from that in within 8 hr after death, and stored at Ϫ70ЊC until used for molecular the more common inherited demyelinating neuropathy, analysis. RNA was extracted from patient V-5, a control human brain, and a 15-day-old rat brain, and analyzed by Northern analysis Charcot-Marie-Tooth disease type IA (CMT1A), in which according to standard protocols (Sambrook et al., 1989) . The memnerve conductions are uniformly slow (Kaku et al., 1993) . neuropathy with liability to pressure palsies (HNPP, MIM RNA extracted from the brain of V-5 and from a normal brain 162500), which is due to deletion of one copy of the (Chomczynski and Sacchi, 1987) was reverse transcribed with AMV reverse transcriptase (Promega) and oligo-dT and random primers PMP22 gene (Chance et al., 1993) , and is often found (Promega) . A portion of the cDNA product was amplified with PLPin acquired demyelinating neuropathies, such as chronic specific 5Ј and 3Ј primers (Ϫ71/Ϫ47 and ϩ535/ϩ559, respectively, inflammatory demyelinating peripheral neuropathy. An according to Diehl et al., 1986) . After a 2 min denaturation at 94ЊC, asymmetric and multifocal pattern of NCV slowing is the reactions were subjected to 35 cycles at 94ЊC for 30 s, 55ЊC for consistent with the presence of regions of normal and 30 s, and 65ЊC for 1 min, followed by a final extension at 65ЊC for 6 min. Sequencing of the PCR product was carried out with an abnormal myelin. This pattern suggests that peripheral internal primer (ϩ64/ϩ87, according to Diehl et al., 1986) or with myelin is formed normally in individuals carrying a G-4 the same primers employed for amplification with the AmpliTaq deletion, and subsequently breaks down, perhaps prefcycle sequencing kit (Perkin-Elmer). One hundred femptomoles of erentially at compression points. PLP is thus also necesthe template, purified with a Qiaquick spin PCR purification kit (Qiasary for maintaining the integrity of the peripheral myelin gen), were annealed with 1.6 fmol of 32 P-labeled primer and sequenced according to the manufacturer's specifications.
sheath.
Western Analysis
followed by methylcellulose-uranyl acetate staining. Several other investigators' PLP antisera were also used, including the carboxy Frontal lobe white matter (1 g) samples obtained from V-5 and V-6 and from a control brain were thawed and homogenized in 7 ml terminus-specific antiserum used for the Western analysis, but failed to give any detectable signal. There was no staining when 0.32 M sucrose (eight strokes each with A and B pestles of a Dounce homogenizer). The homogenates were layered onto 8 ml 0.85 M primary antiserum was omitted. sucrose and then subjected to centrifugation in a Beckman SW 28 rotor at 25,000 rpm for 30 min at 4ЊC. The myelin layer at the interfaceChance, P.F., Alderson, M.K., Leppig, K.A., Lensch, M.W., MatsuImmunogold Ultrastructural Cytochemistry nami, N., Smith, B., Swanson, P.D., Odelberg, S.J., Disteche, C.M., Sciatic nerve was fixed and stored overnight at 4ЊC in 0. 08 M phosand Bird, T.D. (1993) . DNA deletion associated with hereditary neuphate buffer solution containing 2.5% glutaraldehyde and 4% pararopathy with liability to pressure palsies. Cell 72, 143-151. formaldehyde, pH 7.4. Then, the nerve was processed for ultracryoChen, K.-L., Wang, Y.L., Dodson, L.A., Rennert, H., Mochan, B.S., microtomy, as described previously (Tokuyasu, 1973; Vallat et al., Wilson, R.B., and Kant, J.A. (1996) . Normalized Southern hybridiza-1996). Sections 95 nm thick were performed with a Leica Reichert tion to enhance testing for Charcot-Marie-Tooth disease, Type 1A. FCS ultracuts microtome.
Mol. Diag. 1, 65-71. Tissues were collected on carbonate-formvar-coated nickel grids Chomczynski, P., and Sacchi, N. (1987) . Single-step method of RNA and immunostained using a P0 monoclonal antibody at a 1:50,000 isolation by acid guanidinium thiocyanate-phenol-chloroform exdilution (kindly provided by Dr. J. J. Archelos, Wü rzburg, Germany) traction. Anal. Biochem. 162, 156-159. and an undiluted PLP-specific antibody (a gift of Dr. Wendy Macklin, Cleveland Clinic) directed against a peptide corresponding to PLP Diehl, H.J., Schaich, M., Budzinski, R.M., and Stoffel, W. (1986). Individual exons encode the integral membrane domains of human residues 116-150. These antibodies were detected by adding IgGcoated colloidal gold particles (12 nm in diameter, at 1:25 dilution) myelin proteolipid protein [published erratum appears in Proc. Natl.
